MTOR and gestational diabetes: Fetal glucose, amino acids, and placental insulin/IGF 1 signaling act as upstream regulators of the mammalian target of rapamycin (mTOR), which is central to energy sensing and can be reset by maternal obesity and GDM (25) through phosphorylation mechanisms.